Ultrasound sensor specialist Novosound has signed a major deal that will see the firm move into the healthcare sector and expand into North America.
The Glasgow based firm has signed a commercial partnership agreement with US-based PAVmed Inc., the Nasdaq-listed diversified medical technology company, to develop technology aimed at advancing intravascular imaging.
Dave Hughes, Chief Executive and Co-Founder of Novosound, said: “PAVmed has a strong track record in delivering commercial stage medical technology across medical devices, diagnostics, and digital health - the group is the ideal partner for Novosound as we increasingly gain traction in the international healthcare sector.”
